View all staff
Professor Saul Faust

Professor Saul Faust

 MBBS, FRCPCH, PhD, FHEA, OBE
Professor Paediatric Immunology & Infect

Connect with Saul

Email: [email protected]

Tel: +44 23 8120 4989

ORCID
Research Publications External roles and responsibilities Biography
Research Publications External roles and responsibilities Biography

Research

Research groups

Research projects

Active projects

CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia): A randomised trial to assess the use of ciprofloxacin prophylaxis to prevent bacterial infection in children treated on the induction phase of the ALLTogether treatment protocol
Researchers:
Professor Saul Faust
The PICBONE Study
Researchers:
Professor Saul Faust
MISSION (Mid-Infrared Silicon Photonic Sensors for Healthcare and Environmental Monitoring)
Sponsor: EPSRC
AGILE: Seamless Phase I/Iia Platform for the Rapid Evaluation of Candidates for COVID-19 treatment
Sponsor: Medical Research Council
Safety And Immunogenicity Of Nasal Inoculation With Recombinant Neisseria Lactamica Expressing Factor H Binding Protein And Neisseria Adhesin A
Sponsor: Medical Research Council

Completed projects

Prof Rosenberg Directors support
Researchers:
Professor Saul Faust
Sponsor: Wellcome Trust
Investigation of novel adjunctive therapies to improve treatment success in paediatric middle ear infection (otitis media)
Sponsor: Sparks Children's Medical Research Charity
Prof S Faust Wessex Medical Research M12
Researchers:
Professor Saul Faust
Sponsor: Wessex Medical Research
Dr Faust Meningitis Research 0613
Researchers:
Professor Saul Faust
Sponsor: Meningitis Research Foundation
Duration of INtravenous antibiOticc therapy for Septic arthritis or acUte osteomyelitis in a paediatRic population - DINOSAUR
Researchers:
Professor Saul Faust
Biomarker-guided duration of antibiotic treatment in Children Hospitalised with confirmed or suspected bacterial infection
Researchers:
Professor Saul Faust
PRo-adrenomedullin (MR-proADM) Evaluation of procalcitonin-guided antibiotic duration in Children with Infection for Stratification of Effectiveness (PRECISE)
Researchers:
Professor Saul Faust
S Faust DoH: NISEC - 6 in 1 Hepatitis B virus vaccines
Prof R. Read: MRC Experimental Human Challenge with Genetically Modified Commensals to Investigate Respiratory Tract Mucosal Immunity and Colonisation
Sponsor: Medical Research Council
Prof R. Read: A genetically modified nasopharyngeal commensal as a platform for human bacteriotherapy
Sponsor: Medical Research Council
Laser-printable point of care sensors
Sponsor: EPSRC
Transmission Dynamics in Antimicrobial Resistance
Sponsor: Medical Research Council
The National Biofilms Innovation Centre
An Integrated Systems Biology Approach to Bacterial Biofilm Development
Targeting Pneumococcal Carbohydrate Metabolism to Treat Childhood Infections
Sponsor: Rosetrees Trust
New Whole-Species Pneumococcal Biofilm Vaccines
Sponsor: Bill & Melinda Gates Foundation
Novel Pharmaceutical Agents (XF-drugs) to Prevent and Proactively Manage Bacterial Biofilm and Fungal Infections in Dynamic Model Systems
Dr S Clarke - Bupa Carriage Sampling Methods
Sponsor: BUPA Foundation
BioSci - Antabio Research Grant
Sponsor: Antabio
Dr M. Tebruegge: A Proteomic approach to the identification of novel biomarkers of tuberculosis
Sponsor: Wessex Medical Research
Label-free Multimodal Imaging Platform for Detection of Biofilms
Using phages to give new life to old antibiotics against superbugs
Sponsor: Wessex Medical Research
Low Dose Nitric Oxide for the Effective Treatment of Chronic Wounds
Antabio 2 - Pseudomonas elastase inhibitors
Sponsor: Antabio
Personalised approach to Pseudomonas aeruginosa (PAPA)
Development of small molecule inhibitors of the Pseudomonas aeruginosa biofilms to treat chronic infections in cystic fibrosis patients. PHASE II.
Development of Small Molecule Inhibitors of the Pseudomonas aeruginosa Biofilms to Treat Chronic Infections in Cystic Fibrosis Patients. PHASE I.
Southampton AMR Clinical Research Laboratory
How to edit profile